Effect of curcumin on immune function of mice

Li Xinjian , Liu Xiaocheng

Current Medical Science ›› 2005, Vol. 25 ›› Issue (8) : 137 -140.

PDF
Current Medical Science ›› 2005, Vol. 25 ›› Issue (8) : 137 -140. DOI: 10.1007/BF02873559
Article

Effect of curcumin on immune function of mice

Author information +
History +
PDF

Abstract

To investigate the effect of curcumin on immune function of mice, the effect of curcumin was examined on the proliferation of spleen lymphocytes of mice and the function of phagocytosis of peritoneal macrophage by using MTT test and the expression of the nucleoprotein of NFκB p65 was determined in spleen lymphocytes by employing Western Blot. Our results showed that curcumin could enhance the phagocytosis of peritoneal macrophages. Lowdose curcumin could upregulate the proliferation of spleen lymphocytes of mice, and highdose curcumin could suppress the proliferation of spleen lymphocytes. Curcumin could suppress the expression of NFκB p65. Our study suggested that curcumin can regulate immune function of mice in a dosedependent manner. The possible underlying mechanism might be its ability to suppress the activity of NFκB p65.

Keywords

curcumin / lymphocytes / macrophages / NFκB

Cite this article

Download citation ▾
Li Xinjian, Liu Xiaocheng. Effect of curcumin on immune function of mice. Current Medical Science, 2005, 25(8): 137-140 DOI:10.1007/BF02873559

登录浏览全文

4963

注册一个新账户 忘记密码

References

[1]

Pharmacopeia Committee of the People’s Republic of China. Pharmacopeia of the People’s Republic of China (Chinese), 2000, Beijing, Publishing Company of Chemistry and Industry: 218-218

[2]

BianX Y, YangM Y, ZhangY. The application of improved MTT colorimetric assay to measured the proliferation of lymphocytes. J Jilin Med College (Chinese), 1997, 17(2): 28-28

[3]

ZhaoH, GuD W, ZhangS J, et al. . In vitro study of Biola Yedoensis Makino decoetion on regulating immunocyte functions in mice. J Fujian College TCM (Chinese), 2003, 13(2): 27-27

[4]

ZhaoH H. The effect of P substance on regulation of the function of murine peritoneal macrophages. J Immune China (Chinese), 1989, 5(2): 75-75

[5]

DignamJ D, LebovitzR M, RoederR G. Accurate transcription initiation by RNA polymerase II in a solute extract from isolated mammaliannuclei. Nucleic Acid Res, 1983, 111475-1475

[6]

BaeureleP A, HenkelT. Function and activation of NFκB in the immune system. Annu Rev Immunol, 1994, 12141-141

[7]

BielakZ A, KoronkiewiczM, SkierskiJ, et al. . Effect of curcumin on the apoptosis of rodent and human non-proliferating and proliferating lymphoid cells. Nut Cancer, 2000, 38131-131

[8]

ChurchillM, ChadburnA, BilinskiR T, et al. . Inhibition of intestinal tumors by curcumin is associated with changes in the intestinal immune cell profil. J Surg Res, 2000, 89(2): 169-169

[9]

AmmonH P, WahlM A. Pharmacology of Curcuma longa. Plant Med, 1991, 571-1

[10]

GaoX H, JarretK, JiangH, et al. . Immunomodulatory activity of curcumin: suppression of lymphocyte proliferation, development of cellmediated cytotoxicity, and cytokine production in vitro. Biochem Pharmacol, 2004, 6851-51

[11]

NatrajanC, BrightJ J. Curcumin inhibits experimental allergic encephalomyelitis by blocking IL12 signaling through januskinaseSTAT pathway in T lymphocytes. J Immunol, 2002, 1696506-6506

[12]

BhartiA C, DonatoN, SinghS, et al. . Curcumin (difeuloylmethane) downregulates the constitutive activation of nuclear factor κB and IkBa kinase in human multiple myeloma cells, leading to suppression of proliferation and induction of apoptosis. Blood, 2003, 1011053-1053

[13]

MukhopadyayA, BanerjeeS, StaffordL J, et al. . Curcumin induced suppression of cell proliferation correlates with downregulation of cyclin D1 expression and CDK4 mediated retnoblastoma protein phosphorylation. Oncogene, 2002, 218852-8852

[14]

SinghS L, AggarwalB B. Activation of transcription factor NFkB is suppressed by curcumin (diferuloylmethane). J Biol Chem, 1995, 27024995-24995

[15]

WoX D, QiuH X, GaoC X, et al. . Toxicity of curcumin acting for long period. J Zhejiang College TCM (Chinese), 2000, 24(1): 61-61

[16]

ChengAL, HsuC H, LinJ K, et al. . Phase I clinical trial of curcumin, a hemopreventive agent, in patients with highrisk or premalignant lesions. Anticancer Res, 2001, 21(4B): 2895-2895

AI Summary AI Mindmap
PDF

91

Accesses

0

Citation

Detail

Sections
Recommended

AI思维导图

/